Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2011 1
2012 1
2015 1
2016 2
2017 2
2019 2
2020 5
2021 3
2022 5
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
miR-1260b inhibits periodontal bone loss by targeting ATF6β mediated regulation of ER stress.
Hayashi C, Fukuda T, Kawakami K, Toyoda M, Nakao Y, Watanabe Y, Shinjo T, Sano T, Iwashita M, Yotsumoto K, Shida M, Taketomi T, Sanui T, Uchiumi T, Kanematsu T, Nishimura F. Hayashi C, et al. Among authors: kawakami k. Front Cell Dev Biol. 2022 Nov 30;10:1061216. doi: 10.3389/fcell.2022.1061216. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36531939 Free PMC article.
A Phase II Trial of Trifluridine/Tipiracil in Combination with Cetuximab Rechallenge in Patients with RAS Wild-Type mCRC Refractory to Prior Anti-EGFR Antibodies: WJOG8916G Trial.
Izawa N, Masuishi T, Takahashi N, Shoji H, Yamamoto Y, Matsumoto T, Sugiyama K, Kajiwara T, Kawakami K, Aomatsu N, Kondoh C, Kawakami H, Takegawa N, Esaki T, Shimokawa M, Nishio K, Narita Y, Hara H, Sunakawa Y, Boku N, Moriwaki T, Eguchi Nakajima T, Muro K. Izawa N, et al. Among authors: kawakami k. Target Oncol. 2023 May;18(3):369-381. doi: 10.1007/s11523-023-00963-9. Epub 2023 May 6. Target Oncol. 2023. PMID: 37148491 Clinical Trial.
Scaffold-free bone-like 3D structure established through osteogenic differentiation from human gingiva-derived stem cells.
Toyoda M, Fukuda T, Fujimoto R, Kawakami K, Hayashi C, Nakao Y, Watanabe Y, Aoki T, Shida M, Sanui T, Taguchi M, Yamamichi K, Okabe A, Okada T, Oka K, Nakayama K, Nishimura F, Kajioka S. Toyoda M, et al. Among authors: kawakami k. Biochem Biophys Rep. 2024 Feb 15;38:101656. doi: 10.1016/j.bbrep.2024.101656. eCollection 2024 Jul. Biochem Biophys Rep. 2024. PMID: 38379857 Free PMC article.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Aoki M, Kadowaki S, Takahashi N, Suzuki T, Oshima K, Ando T, Yamamoto Y, Kawakami K, Kito Y, Matsumoto T, Shimozaki K, Miyazaki Y, Yamaguchi T, Nagase M, Tamura T, Amanuma Y, Esaki T, Miura Y, Akiyoshi K, Baba E, Makiyama A, Negoro Y, Nakashima K, Sugimoto N, Nagashima K, Shoji H, Boku N. Aoki M, et al. Among authors: kawakami k. Gastric Cancer. 2023 Jan;26(1):132-144. doi: 10.1007/s10120-022-01349-y. Epub 2022 Nov 1. Gastric Cancer. 2023. PMID: 36316527 Free PMC article.
Monolayer platform using human biopsy-derived duodenal organoids for pharmaceutical research.
Yamashita T, Inui T, Yokota J, Kawakami K, Morinaga G, Takatani M, Hirayama D, Nomoto R, Ito K, Cui Y, Ruez S, Harada K, Kishimoto W, Nakase H, Mizuguchi H. Yamashita T, et al. Among authors: kawakami k. Mol Ther Methods Clin Dev. 2021 May 19;22:263-278. doi: 10.1016/j.omtm.2021.05.005. eCollection 2021 Sep 10. Mol Ther Methods Clin Dev. 2021. PMID: 34485610 Free PMC article.
Establishment of a refined culture method for rat colon organoids.
Isshiki H, Arimura Y, Nagaishi K, Kawakami K, Onodera K, Yamashita K, Naishiro Y, Fujimiya M, Imai K, Shinomura Y. Isshiki H, et al. Among authors: kawakami k. Biochem Biophys Res Commun. 2017 Jul 29;489(3):305-311. doi: 10.1016/j.bbrc.2017.05.142. Epub 2017 May 27. Biochem Biophys Res Commun. 2017. PMID: 28559141
Extracellular vesicles derived from GMSCs stimulated with TNF-α and IFN-α promote M2 macrophage polarization via enhanced CD73 and CD5L expression.
Watanabe Y, Fukuda T, Hayashi C, Nakao Y, Toyoda M, Kawakami K, Shinjo T, Iwashita M, Yamato H, Yotsumoto K, Taketomi T, Uchiumi T, Sanui T, Nishimura F. Watanabe Y, et al. Among authors: kawakami k. Sci Rep. 2022 Aug 3;12(1):13344. doi: 10.1038/s41598-022-17692-0. Sci Rep. 2022. PMID: 35922474 Free PMC article.
TRESBIEN (OGSG 2101): encorafenib, binimetinib and cetuximab for early recurrent stage II/III BRAF V600E-mutated colorectal cancer.
Boku S, Satake H, Ohta T, Mitani S, Kawakami K, Suzuki Y, Matsumoto T, Terazawa T, Yamazaki E, Hasegawa H, Ikoma T, Uemura M, Yamaguchi T, Naito A, Ishizuka Y, Kurokawa Y, Sakai D, Kawakami H, Shimokawa T, Tsujinaka T, Kato T, Satoh T, Kagawa Y. Boku S, et al. Among authors: kawakami k. Future Oncol. 2022 Dec;18(38):4153-4160. doi: 10.2217/fon-2022-0949. Epub 2022 Dec 8. Future Oncol. 2022. PMID: 36475784 Free article.
Luteolin Is a Potential Immunomodulating Natural Compound against Pulpal Inflammation.
Kawakami K, Fukuda T, Toyoda M, Nakao Y, Hayashi C, Watanabe Y, Aoki T, Shinjo T, Iwashita M, Yamashita A, Shida M, Sanui T, Uchiumi T, Nishimura F. Kawakami K, et al. Biomed Res Int. 2024 Jan 25;2024:8864513. doi: 10.1155/2024/8864513. eCollection 2024. Biomed Res Int. 2024. PMID: 38304347 Free PMC article.
29 results